Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationDepreciation & Amortization (IS)EBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares OutstandingShares Outstanding
Ratios

LifeStance Health (LFST) Shares Outstanding (2020 - 2025)

LifeStance Health (LFST) has disclosed Shares Outstanding for 6 consecutive years, with $388.3 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding rose 1.46% to $388.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $388.3 million through Dec 2025, up 1.46% year-over-year, with the annual reading at $388.3 million for FY2025, 1.46% up from the prior year.
  • Shares Outstanding for Q4 2025 was $388.3 million at LifeStance Health, roughly flat from $389.0 million in the prior quarter.
  • The five-year high for Shares Outstanding was $389.1 million in Q2 2025, with the low at $374149.0 in Q2 2021.
  • Average Shares Outstanding over 5 years is $281.6 million, with a median of $378.6 million recorded in 2023.
  • The sharpest move saw Shares Outstanding plummeted 99.96% in 2021, then soared 100582.1% in 2023.
  • Over 5 years, Shares Outstanding stood at $374.3 million in 2021, then rose by 0.46% to $376.0 million in 2022, then increased by 0.73% to $378.7 million in 2023, then grew by 1.06% to $382.7 million in 2024, then rose by 1.46% to $388.3 million in 2025.
  • According to Business Quant data, Shares Outstanding over the past three periods came in at $388.3 million, $389.0 million, and $389.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.